[Nelson syndrome: a rare cause of generalized hyperpigmentation of the skin]

Actas Dermosifiliogr. 2010 Jan-Feb;101(1):76-80.
[Article in Spanish]

Abstract

Nelson syndrome is a rare cause of generalized mucocutaneous hyperpigmentation. Its clinical manifestations are due to excessive secretion of adrenocorticotropic hormone from a pituitary adenoma, which develops after bilateral therapeutic adrenalectomy. As this operation has fallen into disuse, Nelson syndrome is now extremely rare and difficult to recognize. We present a very severe case of generalized hyperpigmentation due to Nelson syndrome in a 37-year-old woman.

Publication types

  • Case Reports

MeSH terms

  • Adenoma / complications
  • Adenoma / diagnosis
  • Adenoma / drug therapy
  • Adenoma / etiology*
  • Adenoma / surgery
  • Adrenalectomy / adverse effects*
  • Adult
  • Cabergoline
  • Combined Modality Therapy
  • Dicarboxylic Acids / therapeutic use
  • Ergolines / therapeutic use
  • Female
  • Hormone Replacement Therapy
  • Humans
  • Hydrocortisone / therapeutic use
  • Hypophysectomy
  • Nelson Syndrome / diagnosis
  • Nelson Syndrome / drug therapy
  • Nelson Syndrome / etiology*
  • Nelson Syndrome / pathology
  • Nelson Syndrome / surgery
  • Neoplasms, Multiple Primary
  • Peptides, Cyclic / therapeutic use
  • Pituitary ACTH Hypersecretion / drug therapy
  • Pituitary ACTH Hypersecretion / etiology
  • Pituitary ACTH Hypersecretion / surgery
  • Pituitary Apoplexy / complications
  • Pituitary Apoplexy / surgery
  • Pituitary Neoplasms / complications
  • Pituitary Neoplasms / surgery
  • Radiosurgery
  • Somatostatin / analogs & derivatives
  • Somatostatin / therapeutic use
  • Thyroxine / therapeutic use

Substances

  • Dicarboxylic Acids
  • Ergolines
  • Peptides, Cyclic
  • lanreotide
  • Somatostatin
  • azelaic acid
  • Cabergoline
  • Thyroxine
  • Hydrocortisone